OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer
Adam L. Maddox, Matthew Brehove, Kiarash Rahmani Eliato, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2795-2795
Open Access | Times Cited: 13
Adam L. Maddox, Matthew Brehove, Kiarash Rahmani Eliato, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2795-2795
Open Access | Times Cited: 13
Showing 13 citing articles:
EGFR-directed antibodies promote HER2 ADC internalization and efficacy
Avantika Gupta, Flavia Michelini, Hong Shao, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 11, pp. 101792-101792
Open Access | Times Cited: 5
Avantika Gupta, Flavia Michelini, Hong Shao, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 11, pp. 101792-101792
Open Access | Times Cited: 5
Exomap1 mouse: A transgenic model for in vivo studies of exosome biology
Francis K. Fordjour, Sarah Abuelreich, Xiaoman Hong, et al.
Extracellular Vesicle (2023) Vol. 2, pp. 100030-100030
Open Access | Times Cited: 11
Francis K. Fordjour, Sarah Abuelreich, Xiaoman Hong, et al.
Extracellular Vesicle (2023) Vol. 2, pp. 100030-100030
Open Access | Times Cited: 11
Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases
Lu Wang, Yu‐Sheng Lin, Zhimeng Yao, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101118-101118
Open Access | Times Cited: 4
Lu Wang, Yu‐Sheng Lin, Zhimeng Yao, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101118-101118
Open Access | Times Cited: 4
Multiparametric profiling of HER2-enriched extracellular vesicles in breast cancer using Single Extracellular VEsicle Nanoscopy
Nan Jiang, András Saftics, Eugenia Romano, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Nan Jiang, András Saftics, Eugenia Romano, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Single Extracellular VEsicle Nanoscopy-Universal Protocol (SEVEN-UP): Accessible Imaging Platform for Quantitative Characterization of Single Extracellular Vesicles
András Saftics, B. A. Purnell, Bálint Béres, et al.
Analytical Chemistry (2025)
Open Access
András Saftics, B. A. Purnell, Bálint Béres, et al.
Analytical Chemistry (2025)
Open Access
Syntenin and CD63 Promote Exosome Biogenesis from the Plasma Membrane by Blocking Cargo Endocytosis
Yiwei Ai, Chenxu Guo, Marta Garcia‐Contreras, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Yiwei Ai, Chenxu Guo, Marta Garcia‐Contreras, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Exomap1 mouse: a transgenic model forin vivostudies of exosome biology
Francis K. Fordjour, Sarah Abuelreich, Xiaoman Hong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Francis K. Fordjour, Sarah Abuelreich, Xiaoman Hong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Interobserver Variability in HER ‐2 Immunostaining Interpretation of Metastatic HER2 Low Breast Cancers in Cytology Specimens
Niyati Desai, Courtney Connelly, Simon Sung, et al.
Diagnostic Cytopathology (2024) Vol. 52, Iss. 12, pp. 722-730
Closed Access | Times Cited: 1
Niyati Desai, Courtney Connelly, Simon Sung, et al.
Diagnostic Cytopathology (2024) Vol. 52, Iss. 12, pp. 722-730
Closed Access | Times Cited: 1
荧光原位杂交扩增探针的结构光照明超分辨成像与计数
吴寅 Wu Yin, 梁永 Liang Yong, 张洁 Zhang Jie, et al.
Laser & Optoelectronics Progress (2024) Vol. 61, Iss. 4, pp. 0411009-0411009
Open Access | Times Cited: 1
吴寅 Wu Yin, 梁永 Liang Yong, 张洁 Zhang Jie, et al.
Laser & Optoelectronics Progress (2024) Vol. 61, Iss. 4, pp. 0411009-0411009
Open Access | Times Cited: 1
Using quantitative single molecule localization microscopy to optimize multivalent HER2-targeting ligands
Devin L. Wakefield, Ottavia Golfetto, Raphaël Jorand, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Devin L. Wakefield, Ottavia Golfetto, Raphaël Jorand, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Molecular Atlas of HER2+ Breast Cancer Cells Treated with Endogenous Ligands: Temporal Insights into Mechanisms of Trastuzumab Resistance
Kavitha Mukund, Jackelyn A. Alva-Ornelas, Adam L. Maddox, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 553-553
Open Access
Kavitha Mukund, Jackelyn A. Alva-Ornelas, Adam L. Maddox, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 553-553
Open Access
TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2+ breast cancer
Xinyi Shao, Dawei Yang, Liuqun Shan, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 865-881
Closed Access
Xinyi Shao, Dawei Yang, Liuqun Shan, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 865-881
Closed Access
Neratinib enhances the efficacy of CDK4/6 inhibitor plus endocrine therapy in HR+/HER2-low breast cancer cell line ZR-75-1 via hsa-miR-23a-5p
Liushan Chen, Lingling Ye, Yuqi Liang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Liushan Chen, Lingling Ye, Yuqi Liang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
